Anika Therapeutics | ANIK - PE Price to Earnings


Anika Therapeutics reported 47.54 in PE Price to Earnings for its fiscal quarter ending in June of 2024.





Pe Change Date
Abbott 30.71 14.41 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Anika Therapeutics 47.54 27.2 Jun/2024
Halozyme Therapeutics 23.16 7.7 Dec/2025
Integra LifeSciences 6.58 0.5 Dec/2025
Intrexon 7.54 221.44 Dec/2021
J&J 23.62 0.86 Dec/2025
Ligand Pharmaceuticals 60.65 17.62 Sep/2025
Merit Medical Systems 39.12 6.7 Sep/2025
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Sanofi 11.99 1.58 Dec/2025
Smith & Nephew 17.63 4.2 Dec/2025
Stryker 32.13 2.69 Dec/2025
Surmodics 386.18 225.66 Dec/2021
Veracyte 45.3 5.4 Dec/2025
Xencor 29.92 3.22 Sep/2022
Zimmer Biomet Holdings 17.91 3.5 Dec/2025